Skip to main content
. 2025 Aug 15;104(33):e43981. doi: 10.1097/MD.0000000000043981

Table 3.

Univariate binary logistic regression of PTDM risk factors in KTx patients.

Variable N OR 95% CI P-value
Dialysis modality before KTx 130
 HD
 PD 0.80 0.25, 2.26 .7
 PREE 0.68 0.10, 2.83 .6
Gender 130
 Female
 Male 0.83 0.35, 1.96 .7
Age (yr) 130 1.04 1.01, 1.08 .019
BMI kg/m2 130 1.12 1.01, 1.25 .044
BMI ≥ 30 130
 0
 1 2.26 0.71, 6.63 .15
Number 130
 1st
 2nd and 3rd KTx 0.38 0.02, 2.17 .4
Pre-transplant dialysis time (mo) 128 0.99 0.98, 1.00 .3
Number of HLA mismatches 130 1.08 0.77, 1.52 .7
Cause of ESRD 130
 GN
 ADPKD 1.88 0.37, 7.73 .4
 IN 0.83 0.12, 3.65 .8
 Not known 1.00 0.14, 4.51 >.9
 HN/IschN 2.92 0.91, 9.09 .065
 Other (a/HUS) 3.00 0.55, 14.2 .2
Induction use (basiliximab/anti-thymocyte globulin) 130
 0
 1 2.00 0.78, 5.83 .2
Tacrolimus use (0), Cyclosporin use (1) 130
 0
 1 0.44 0.10, 1.40 .2
2-wk cumulative methylprednisolon dose 130 0.73 0.34, 1.46 .4
AR 130
 0
 1 1.88 0.25, 10.2 .5
DGF 130
 0
 1 0.57 0.16, 1.67 .3
CSC 1 mo after KTx (mg/dL) 130 0.91 0.48, 1.50 .7
eGFR 4p MDRD 1 mo after KTx (mL/min/1.73 m2) 130 1.00 0.98, 1.01 .9
Duration of hospitalization after KTx (days) 130 1.01 0.95, 1.06 .8
CMV infection 130
 0
 1 0.79 0.12, 3.33 .8
UTI 130
 0
 1 1.93 0.67, 5.23 .2
WIT (min) 129 1.03 0.98, 1.09 .2
CIT (min) 128 1.00 1.00, 1.00 .073
HbA1c before KTx (mmol/mol) 125 3.69 1.26, 12.0 .022
HbA1c > 5.7 mmol/mol 125
 0
 1 4.45 1.48, 13.5 .007
Glycemia before KTx (mg/dL) 123 1.04 1.01, 1.08 .021
Glycemia before KTx > 99 (mg/dL) 130
 0
 1 3.92 1.25, 12.1 .017
Insulin level before KTx (µU) 123 1.02 0.97, 1.07 .4
HOMA-IR Index before KTx 119 1.08 0.92, 1.27 .3
HOMA over the normal range before KTx > 2 119
 0
 1 1.76 0.69, 4.36 .2
QUICKI under the normal range before KTx < 0.34 119
 0
 1 2.16 0.77, 5.77 .13
TyG index 122 1.68 0.72, 4.04 .2
Homocysteine before KTx (µmol) 125 1.00 0.97, 1.03 .8
Homocysteine before KTx (µmol) over the normal range ≥ 15 µmol 130
 0
 1 1.75 0.60, 6.39 .3
Cholesterol before KTx (mg/dL) 127 1.00 0.99, 1.01 .6
Triglyceride before KTx (mg/dL) 127 1.00 1.00, 1.01 .4
HDL cholesterol before KTx (mg/dL) 126 1.00 0.97, 1.03 >.9
LDL cholesterol before KTx (mg/dL) 126 1.00 0.99, 1.01 .6
Uric acid before KTx (mg/dL) 124 0.89 0.69, 1.14 .4
C-peptide before KTx (ng/mL) 128 1.03 0.95, 1.11 .5
Albumin before KTx (g/L) 127 0.76 0.23, 2.39 .6

ADPKD = autosomal dominant polycystic kidney disease; AR = acute rejection; BMI = body mass index; CI = confidence interval; CIT = cold ischemia time; CSC = creatinine serum concentration; DGF = delayed graft function; eGFR CKD-EPI = estimated glomerular filtration rate and chronic kidney disease epidemiology collaboration; eGFR 4p MDRD = estimated glomerular filtration rate and 4-point modification of diet in renal disease formula; ESRD = end-stage renal disease; HBA1c = glycosylated hemoglobin, Type A1c; HD = hemodialysis; HDL = high-density lipoprotein; HLA = human leucocytes antigens; IschN = ischemic nephropathy; HOMA-IR Index = homeostatic model assessment of insulin resistance index; HUS = hemolytic uremic syndrome; KTx = kidney transplantation; N = number of patients; OR = odds ratio; PD = peritoneal dialysis; PREE = preemptive kidney transplantation; QUICKI = quantitative insulin-sensitivity check index; TyG index = triglycerides and glucose index; WIT = warm ischemia time.